Litmus Health Achieves HIPAA and FISMA Compliance for Real World Data Infrastructure
This morning, we were pleased to announce that Litmus Health underwent an extensive third-party assessment of the company’s security practices that deemed our infrastructure to be secure and compliant. This includes both HIPAA and FISMA compliance, as well as adherence to the NIST cybersecurity framework.
We’re proud of this work and excited to be leading the way for data security and privacy for real-world data collection in the pharmaceutical industry.
Five years ago, few companies in the industry truly understood how impactful real-world data would become. Now, few would dispute its value in helping researchers and clinicians understand the full capabilities and benefits of their therapies. It has been incredibly gratifying to see the industry’s widespread adoption of real-world evidence, and we at Litmus are proud of the ways we’ve been able to help our partners incorporate these exciting new data from wearables and sensors into their clinical trials.
With the continued rise of real-world data collection in the pharma industry, there has been increased demand for industry-wide data standards and established security protocols to ensure data integrity. With this announcement, we’re proud to continue to lead on defining rigorous standards for data safety and security, as well as demonstrating our robustness and transparency.
Our assessment was completed by IT Federal Services, a commercial security services organization specializing in providing information assurance and cybersecurity consulting services to government and commercial organizations. We are proud to share that IT Federal Services found Litmus infrastructure to be secure and compliant when measured against federal security regulations.
This adherence to federal security standards has served as the foundation of our technology over the years. As a company, one of our founding goals is to help researchers increase the certainty of their conclusions and describe the full value of their work. We understand that this goal can only be achieved through dedication to top-notch security practices and processes. We feel it is our responsibility to ensure the accuracy, security, and privacy of real-world data for those on front lines of cutting-edge science and pharmaceutical research.
At Litmus, we handle the engineering so you can focus on the science. As researchers, clinicians, and data scientists ourselves, we also recognize the essential needs of regulatory compliance and the associated constraints that our customers face each day. With our recent announcement of our third-party assessment of the company’s security practices, we are poised to continue leading this charge into the future.
With reliable data engineering, first-rate data quality, and flexible deployment, the Litmus platform is used by pharma companies globally that are looking to effectively integrate real world data into clinical trials. If you’re ready to incorporate real-life data into your observational study, therapeutic trial, or post-market research, then we’re ready for you. We look forward to working with you soon.